Abstract Purpose of Review To summarize current approaches in the management of brain
metastases from non-small cell lung cancer (NSCLC). Recent Findings Local treatment has …

Non-small-cell lung cancer (NSCLC) brain metastases are common. Even though there are
various subsets of NSCLC with molecular alterations, there is a common theme of brain …

Lung cancer is characterized by the highest incidence of solid tumor-related brain
metastases, which are reported with a growing incidence during the last decade. Prognostic …

Opinion statement Brain metastases are common in patients with non-small cell lung cancer
(NSCLC), and due to associated poor prognosis, this field is an important area of need for …

Brain metastases are common in patients with non-small-cell lung cancer (NSCLC).
Because of associated poor prognosis and limited specific treatment options, there is a real …

Multimodality management of non-small cell lung cancer patie... : Current Opinion in
Oncology Multimodality management of non-small cell lung cancer patients with brain …

Brain metastases from non-small cell lung cancer develop in approximately one-third of
patients. If not treated, neurological deterioration occurs quickly. Treatment with whole brain …

Brain metastases from lung cancer represent a prevalent and challenging clinical dilemma.
The brain is an extremely common site of failure for non-small-cell lung cancer and small …

Despite the high prevalence of brain metastases in patients with metastatic lung cancer,
these patients have been excluded from enrollment in clinical trials of new therapeutic …

ABSTRACT Introduction: Brain metastases (BMs) develop in up to 40% of patients with non-
small cell lung cancer (NSCLC). In many recent practice-changing clinical trials, patients …